The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ACADIA PHARMACEUTICALS INC | COM | 004225108 | 24,097,835 | 769,653 | SH | SOLE | 769,653 | 0 | 0 | ||
AMICUS THERAPEUTICS INC | COM | 03152W109 | 21,129,265 | 1,489,025 | SH | SOLE | 1,489,025 | 0 | 0 | ||
ARVINAS INC | COM | 04335A105 | 20,773,452 | 504,700 | SH | SOLE | 504,700 | 0 | 0 | ||
ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | 20,627,083 | 163,772 | SH | SOLE | 163,772 | 0 | 0 | ||
CHURCHILL CAPITAL CORP VII | *W EXP 02/29/202 | 17144M110 | 71,295 | 548,000 | SH | SOLE | 548,000 | 0 | 0 | ||
COMPASS DIGITAL ACQUISITION CORP | *W EXP 09/29/202 | G2476C123 | 22,259 | 459,906 | SH | SOLE | 459,906 | 0 | 0 | ||
CONCORD ACQUISITION CORP II | *W EXP 99/99/999 | 20607U116 | 53,083 | 408,333 | SH | SOLE | 408,333 | 0 | 0 | ||
CYTOKINETICS INC | COM NEW | 23282W605 | 36,042,049 | 431,693 | SH | SOLE | 431,693 | 0 | 0 | ||
CALIDI BIOTHERAPEUTICS INC | COM NEW | 320703101 | 188,750 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
CALIDI BIOTHERAPEUTICS INC | *W EXP 03/14/202 | 320703119 | 32,760 | 655,200 | SH | SOLE | 655,200 | 0 | 0 | ||
GALAPAGOS NV | SPON ADR | 36315X101 | 18,644,488 | 458,659 | SH | SOLE | 458,659 | 0 | 0 | ||
HOME PLATE ACQUISITION CORP | *W EXP 09/30/202 | 43734R111 | 20,014,212 | 331,416 | SH | SOLE | 331,416 | 0 | 0 | ||
LIBERTY BROADBAND CORP | COM SER C | 530307305 | 14,865,631 | 184,460 | SH | SOLE | 184,460 | 0 | 0 | ||
MARBLEGATE ACQUISITION CORP | *W EXP 08/31/202 | 56608A113 | 22,050 | 735,000 | SH | SOLE | 735,000 | 0 | 0 | ||
MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | 62,740 | 895,000 | SH | SOLE | 895,000 | 0 | 0 | ||
MORPHIC HOLDING INC | COM | 61775R105 | 14,349,201 | 496,856 | SH | SOLE | 496,856 | 0 | 0 | ||
PROTHENA CORP PLC | SHS | G72800108 | 12,693,562 | 349,300 | SH | SOLE | 349,300 | 0 | 0 | ||
RELAY THERAPEUTICS INC | COM | 75943R102 | 14,509,749 | 1,317,870 | SH | SOLE | 1,317,870 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 17,698,428 | 617,100 | SH | SOLE | 617,100 | 0 | 0 | ||
ROSS ACQUISITION CORP II | *W EXP 02/01/202 | G7641C114 | 24,621 | 439,666 | SH | SOLE | 439,666 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 14,016,776 | 145,357 | SH | SOLE | 145,357 | 0 | 0 | ||
SOLID BIOSCIENCES INC | COM NEW | 83422E204 | 5,902,081 | 961,251 | SH | SOLE | 961,251 | 0 | 0 | ||
SPIRIT AIRLINES INC | COM | 848577102 | 27,863,000 | 1,700,000 | SH | Call | SOLE | 1,700,000 | 0 | 0 | |
SPRINGWORKS THERAPEUTICS INC | COM | 85205L107 | 20,327,872 | 556,928 | SH | SOLE | 556,928 | 0 | 0 | ||
SWIFTMERGE ACQUISITION CORP | *W EXP 12/13/202 | G63836111 | 20,090 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | 12,903,536 | 1,435,321 | SH | SOLE | 1,435,321 | 0 | 0 | ||
YS BIOPHARMA CO LTD | *W EXP 03/15/202 | G9845F117 | 13,279 | 489,999 | SH | SOLE | 489,999 | 0 | 0 |